Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/ALLAKOS-INC-44979204/actualite/Allakos-Inc-Annonce-le-lancement-d-un-essai-clinique-de-phase-2b-sur-le-lirentelimab-sous-cutane-d-41760054/?utm_source=whatsapp&utm_medium=social&utm_campaign=share